VSEE HEALTH, INC. (VSEE): Material weakness disclosed
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
Related to Our Operation of Business In connection with the preparation of our financial statements for the fiscal year ended December 31, 2024, we identified material weaknesses in our internal control over financial reporting and clinical trial expenses.
Why it matters
A material weakness is a deficiency in internal control over financial reporting that could allow a material misstatement to go undetected.